InDex Pharmaceuticals Holding AB (publ)

OM:INDEX Rapporto sulle azioni

Cap. di mercato: SEK 286.6m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

InDex Pharmaceuticals Holding Salute del bilancio

Salute finanziaria criteri di controllo 6/6

InDex Pharmaceuticals Holding has a total shareholder equity of SEK236.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK280.9M and SEK44.9M respectively.

Informazioni chiave

0%

Rapporto debito/patrimonio netto

SEK 0

Debito

Indice di copertura degli interessin/a
ContantiSEK 269.82m
Patrimonio nettoSEK 235.98m
Totale passivitàSEK 44.92m
Totale attivitàSEK 280.90m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost

Jun 13
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost

Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce

Apr 28
Further Upside For InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Shares Could Introduce Price Risks After 26% Bounce

We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate

Jul 11
We're Keeping An Eye On InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Rate

We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Jan 21
We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Aug 31
We Think InDex Pharmaceuticals Holding (STO:INDEX) Can Afford To Drive Business Growth

Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation

Mar 29
Here's Why We're Watching InDex Pharmaceuticals Holding's (STO:INDEX) Cash Burn Situation

InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.

Feb 04
InDex Pharmaceuticals Holding's (STO:INDEX) Shareholders Are Down 24% On Their Investment Over The Past Year.

How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?

Dec 21
How Much Are InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Insiders Spending On Buying Shares?

Analisi della posizione finanziaria

Passività a breve termine: INDEX's short term assets (SEK278.4M) exceed its short term liabilities (SEK43.6M).

Passività a lungo termine: INDEX's short term assets (SEK278.4M) exceed its long term liabilities (SEK1.3M).


Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: INDEX is debt free.

Riduzione del debito: INDEX has not had any debt for past 5 years.


Bilancio


Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: INDEX has sufficient cash runway for more than 3 years based on its current free cash flow.

Previsione Cash Runway: INDEX has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 0.2% each year


Scoprire le aziende sane